Download Handouts: https://bit.ly/2S7mPmm

Link to Comment: https://www.regulations.gov/comment?D=FDA-2018-D-4533-0001

Clinical Compounding Pharmacist Matt Martin, PharmD, and Chris Simmons, RPh, Vice President of Creative Development, host an informational webinar to discuss the proposed FDA Guidance for Industry #256, “Compounding Animal Drugs from Bulk Drug Substances.” They will give a general overview and point out some specific concerns pertaining to both pharmacists and veterinarians. They will also explain how pharmacists and veterinarians can submit comments to the FDA. There will be a question-and-answer period at the end of the webinar.